KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Synopsys (SNPS) Research & Development (2016 - 2026)

Synopsys' Research & Development history spans 18 years, with the latest figure at $715.0 million for Q1 2026.

  • For Q1 2026, Research & Development rose 29.24% year-over-year to $715.0 million; the TTM value through Jan 2026 reached $2.6 billion, up 25.17%, while the annual FY2025 figure was $2.5 billion, 19.06% up from the prior year.
  • Research & Development reached $715.0 million in Q1 2026 per SNPS's latest filing, down from $746.8 million in the prior quarter.
  • In the past five years, Research & Development ranged from a high of $746.8 million in Q4 2025 to a low of $371.1 million in Q4 2022.
  • Average Research & Development over 5 years is $514.3 million, with a median of $493.1 million recorded in 2024.
  • Peak YoY movement for Research & Development: decreased 10.34% in 2022, then soared 34.61% in 2025.
  • A 5-year view of Research & Development shows it stood at $371.1 million in 2022, then grew by 25.53% to $465.8 million in 2023, then rose by 19.11% to $554.8 million in 2024, then skyrocketed by 34.61% to $746.8 million in 2025, then dropped by 4.27% to $715.0 million in 2026.
  • Per Business Quant, the three most recent readings for SNPS's Research & Development are $715.0 million (Q1 2026), $746.8 million (Q4 2025), and $625.3 million (Q3 2025).